Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Latigo Biotherapeutics
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject is male or female aged 18 to 65 years
Scheduled to undergo an elective "partial" abdominoplasty under general anesthesia
Has a body BMI 18.0 to 35 kg/m2
Has signed informed consent and will comply with the requirements and restrictions of the study
Meet lifestyle, medication, or other study restrictions
Subject must agree to study required use of birth control
Post-surgical (abdominoplasty) pain must meet the study threshold
You may not be if
Inability to take oral medications
Prior abdominoplasty or a prior intra-abdominal and/or pelvic surgery (including hysterectomy and Cesarean section) that resulted in any complications
History of impaired hepatic function or heart disease.
Abnormal liver laboratories or other lab abnormality indicative of serious medical condition
Sensory abnormality that would confound post-surgery pain assessments
Chronic use of NSAIDs, benzodiazepines, opioid use within the last year, use of medications that prolong QTc intervals, or other dietary and medication restrictions
A subject with sleep apnea and/or on a home continuous positive airway pressure machine.
Positive drug screen.
Clareo Health | An Efficacy and Safety Study of LTG-001 Following Abdominoplasty
